Integrative Medicine for Respiratory Conditions

Yeh, Gloria Y.; Horwitz, Randy

doi:10.1016/j.mcna.2017.04.008

Cited by 24 publications

(13 citation statements)

References 85 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Respiratory diseases entail conditions such as chronic obstructive pulmonary disease (COPD), asthma, occupational lung diseases, and pulmonary hypertension [1]. Globally, these diseases affect millions of people across diverse ages and account for significant levels of disability and mortality especially in children less than 5 years [2][3][4][5].…”

Section: Introductionmentioning

confidence: 99%

Ethnobotanical Survey of Plants Used for Treating Cough Associated with Respiratory Conditions in Ede South Local Government Area of Osun State, Nigeria

Lawal

Olufade

Rafiu

et al. 2020

Plants

View full text Add to dashboard Cite

In many developing countries, community members depend on their local flora for treating diverse ailments including those affecting the respiratory system. This is often attributed to the high cost and limited access to health care facilities. This present study focused on the documentation of plant species used against cough associated with the respiratory diseases in Ede South Local Government Area of Osun State. The survey was conducted using semi-structured interviews among 100 participants. Information obtained was analyzed using different ethno-botanical indices including relative frequency of citation (RFC) and fidelity level (FL). A total of 87 plant species from 39 families, which was mostly represented by Fabaceae, were reported in the study area. Crinum jagus was the most popular plant used against cough and approximately 32% of the plants have been reported as cough remedies for the first time. However, some of the documented plants have been reported for the treatment of cough and related respiratory diseases in several countries. In terms of the life-form, trees constituted the highest proportion of the medicinal plants (37%), while leaves (36%) were the predominant plant part prescribed for cough. Decoction was the main method of preparing the plants, which were all administered orally. Approximately 63% of the plants were exclusively sourced from the wild. The current study revealed the richness and widespread use of plant species for managing cough associated with respiratory diseases in the study area. The generated inventory contributes to the expanding database of valuable plant resources with medicinal potential in Nigeria and Africa.

show abstract

Section: Introductionmentioning

confidence: 99%

Ethnobotanical Survey of Plants Used for Treating Cough Associated with Respiratory Conditions in Ede South Local Government Area of Osun State, Nigeria

Lawal

Olufade

Rafiu

et al. 2020

Plants

View full text Add to dashboard Cite

show abstract

“…The role of psychoemotional factors in COPD disease management and healthcare engagement is well recognised. 65 66 and there is increasing interest in behavioural medicine approaches. 67 For example, psychological distress, including depression and anxiety is prevalent in COPD and increases risk of exacerbation.…”

Section: Discussionmentioning

confidence: 99%

BEAM study (Breathing, Education, Awareness, Movement): a randomised controlled feasibility trial of tai chi exercise in patients with COPD

et al. 2020

Self Cite

View full text Add to dashboard Cite

BackgroundDespite therapeutic advances, the management of chronic obstructive pulmonary disease (COPD) remains complex. There is growing interest in multidimensional, mind-body exercises to improve both physical and psychosocial aspects of COPD burden. Few US data are available in this population on tai chi (TC) a mind-body exercise incorporating physical activity, breathing and mindful awareness. We explored feasibility and preliminary efficacy of TC in COPD in an US academic medical setting.MethodsPatients with COPD Global Obstructive Lung Disease (GOLD) stages 2–4 were randomised to a 12-week TC programme or education control. At 12 weeks, those in TC were randomised again to continue in maintenance classes or not to further explore optimal duration. All groups were followed to 24 weeks. Feasibility/safety parameters were analysed descriptively. Preliminary between-group differences were estimated in symptoms (dyspnoea, fatigue), health-related quality-of-life (Chronic Respiratory Questionnaire CRQ), cognitive-emotional measures (mood, COPD self-efficacy) and functional status (6 min walk test, lower body strength, flexibility, physical activity).ResultsNinety-two subjects were randomised (N=61 TC, N=31 education). Mean age was 68±8 years, 66% male, mean forced expiratory volume in 1 s % predicted 57±13, 28% were GOLD stage 3–4. Overall retention was 85%. Nineteen adverse events occurred, most being study-unrelated COPD exacerbations. From baseline to 12 weeks, there were between-group improvements favouring TC, in CRQ-total (Cohen’s d effect size (ES)=0.46; adj mean diff (AMD)=0.31), CRQ-emotion (ES=0.54; AMD=0.49), Centre for Epidemiologic Studies Depression (ES=−0.37; AMD=2.39) and Patient-Reported Outcome Measurement Information System (PROMIS)-fatigue (ES=−0.34; AMD=−0.17). From baseline to 24 weeks, there was an improvement favouring TC in CRQ-dyspnoea (ES=0.41; AMD=0.46). Among TC participants, there was a positive effect of maintenance classes on self-efficacy (ES=−0.69; AMD=−0.40), 6 min walk (ES=0.56; AMD=49.26 feet), PROMIS-fatigue (ES=−0.41; AMD=−0.28) and chair stand (0.43; AMD=0.56).ConclusionTC in patients with COPD is feasible and safe. Preliminary analyses support a potential modest role in improving quality-of-life, cognitive-emotional health and function that should be further studied.Trial registration numberNCT01551953.IRB referenceBIDMC 2010P-000412; VA 2540.

show abstract

“…However, no significant association was found between vitamin B12 supplementation and a reduced risk of asthma or wheeze [91,92]. Pharmaceutical companies are involved in manufacturing supplements purported for use in asthma such as quercetin and pycnogenol [93]. Quercetin is one of the most natural polyphenolic antioxidants found in many food products, which exerts anti-allergic effects by suppressing airway hyperresponsiveness and eosinophil chemoattractants induced by periostin, leading to reduced risk of asthma and allergic diseases [94].…”

Section: Data Applications and Influencesmentioning

confidence: 99%

Supplements for Smoking-Related Lung Diseases

Alsharairi¹

2021

Encyclopedia

View full text Add to dashboard Cite

Supplements for smoking-related lung diseases are considered as nonfood products and thought to improve health. Multivitamins and antioxidants are the most commonly dietary supplements used by cancer and asthma patients. There are currently no clear regulatory guidelines that include dietary supplements and their effect on lung cancer and asthma patients, particularly in smokers. Several countries have taken steps to overcome challenges in regulating dietary supplements in the marketplace. These challenges include inadequate assurance of safety/efficacy, inaccuracy of product labeling, misleading health claims, and lack of analytical techniques for dietary supplements. There is a need to establish standards and regulation of dietary supplement use in patients with lung cancer and asthma. The aim of this entry is to expand knowledge on dietary supplements use and smoking-related lung diseases (lung cancer and asthma).

show abstract

Integrative Medicine for Respiratory Conditions

Cited by 24 publications

References 85 publications

Ethnobotanical Survey of Plants Used for Treating Cough Associated with Respiratory Conditions in Ede South Local Government Area of Osun State, Nigeria

Ethnobotanical Survey of Plants Used for Treating Cough Associated with Respiratory Conditions in Ede South Local Government Area of Osun State, Nigeria

BEAM study (Breathing, Education, Awareness, Movement): a randomised controlled feasibility trial of tai chi exercise in patients with COPD

Supplements for Smoking-Related Lung Diseases

Contact Info

Product

Resources

About